Robert Floch
Chief Executive Officer at DrugAbuse Pharmaceutical, Inc.
Profile
Robert Floch is currently the Chief Executive Officer at DrugAbuse Pharmaceutical, Inc. He previously held positions as Director of Research & Development at Rhone Merieux, General Manager-European Operations at SangStat Medical Corp., Principal at Merial SAS, and Vice President-Clinical Development at Effimune SA. He obtained a doctorate degree from the University of Nantes.
Robert Floch active positions
| Companies | Position | Start |
|---|---|---|
DrugAbuse Pharmaceutical, Inc.
 DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Chief Executive Officer | 30/09/2003 |
Former positions of Robert Floch
| Companies | Position | End |
|---|---|---|
Merial SAS
 Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Corporate Officer/Principal | - |
Rhone Merieux
 Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Chief Tech/Sci/R&D Officer | - |
Effimune SA
 Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Chief Tech/Sci/R&D Officer | - |
| SangStat Medical Corp. | Corporate Officer/Principal | - |
Training of Robert Floch
| University of Nantes | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
| SangStat Medical Corp. | Health Technology |
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Health Technology |
- Stock Market
- Insiders
- Robert Floch